This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Filicori, M. Articles by Ciampaglia, W. Search for Related Content PubMed PubMed Citation Articles by Filicori, M. Articles by Ciampaglia, W.

Stimulation and Growth of Antral Ovarian Follicles by Selective LH Activity Administration in Women

Reproductive Endocrinology Center, University of Bologna, Bologna 40138, Italy

Address all correspondence and requests for reprints to: Prof. Marco Filicori, Reproductive Endocrinology Center, Department of Obstetrics and Gynecology, University of Bologna, Via Massarenti 13, 40138 Bologna, Italy. E-mail: . filicori{at}med.unibo.it

Abstract

Intensive FSH stimulation is a key tool of assisted reproduction technology but can cause severe complications through the development of an excessive number of small ovarian follicles. We tested the hypothesis that, in the late stages of ovulation induction, LH activity in the form of low-dose human CG (hCG) can stimulate and selectively modulate ovarian follicle function and growth, independently of FSH administration. Four groups of GnRH agonist-suppressed normoovulatory women (10 each group) received recombinant human FSH (r-hFSH) (150 IU/d) for 7 d followed by: group A, r-hFSH 150 IU/d alone; group B, r-hFSH 50 IU/d and hCG 50 IU/d; group C, r-hFSH 25 IU/d and hCG 100 IU/d; group D, hCG 200 IU/d alone. Despite several days of lowered or absent r-hFSH administration, 70% of hCG-treated patients successfully completed treatment. In these subjects, preovulatory E2 levels and large (>14 mm diameter) ovarian follicle development were not reduced; conversely, the number of small (<10 mm diameter) ovarian follicles was significantly decreased in groups B–D vs. group A. Low-dose hCG administration did not cause follicle luteinization. We conclude that, following FSH priming, LH activity administration can: 1) stimulate folliculogenesis for several days, in spite of rapidly declining FSH levels; and 2) hasten small follicle demise. Therefore, LH activity administration could be used to design radically novel ovulation induction regimens that, by partly or completely replacing mid-/late follicular phase FSH administration, may reduce costs and improve safety of assisted reproduction technology.

This article has been cited by other articles:

				S. Ziebe, K. Lundin, R. Janssens, L. Helmgaard, J.-C. Arce, and for the MERIT (Menotrophin vs Recombinant FSH in v Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF Hum. Reprod., September 1, 2007; 22(9): 2404 - 2413. [Abstract] [Full Text] [PDF]

				R. Mansour, M. Aboulghar, G. Serour, Y. Amin, and A. M. Abou-Setta Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome Hum. Reprod., November 1, 2005; 20(11): 3167 - 3172. [Abstract] [Full Text] [PDF]

				J.N. Hugues, J. Soussis, I. Calderon, J. Balasch, R.A. Anderson, A. Romeu, and on behalf of the Recombinant LH Study Group Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study Hum. Reprod., March 1, 2005; 20(3): 629 - 635. [Abstract] [Full Text] [PDF]

				D. DE ZIEGLER, C. MATTENBERGER, C. SCHWARZ, V. IBECHEOLE, N. FOURNET, and F. BIANCHI-DEMICHELI New Tools for Optimizing Endometrial Receptivity in Controlled Ovarian Hyperstimulation: Aromatase Inhibitors and LH/minihCG Ann. N.Y. Acad. Sci., December 1, 2004; 1034(1): 262 - 277. [Abstract] [Full Text] [PDF]

				J.A. Garcia-Velasco, A. Zuniga, A. Pacheco, R. Gomez, C. Simon, J. Remohi, and A. Pellicer Coasting acts through downregulation of VEGF gene expression and protein secretion Hum. Reprod., July 1, 2004; 19(7): 1530 - 1538. [Abstract] [Full Text] [PDF]

				A. J. Zeleznik, L. Little-Ihrig, and S. Ramasawamy Administration of Dihydrotestosterone to Rhesus Monkeys Inhibits Gonadotropin-Stimulated Ovarian Steroidogenesis J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 860 - 866. [Abstract] [Full Text] [PDF]

				E. Loumaye, P. Engrand, Z. Shoham, S.G. Hillier, and D.T. Baird Clinical evidence for an LH ceiling? Hum. Reprod., December 1, 2003; 18(12): 2719 - 2720. [Full Text] [PDF]

				M. Filicori, G. E. Cognigni, and W. Ciampaglia What clinical evidence for an LH ceiling? Hum. Reprod., July 1, 2003; 18(7): 1556 - 1557. [Full Text] [PDF]

				Z. Kilani, A. Dakkak, S. Ghunaim, G.E. Cognigni, C. Tabarelli, L. Parmegiani, and M. Filicori A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes Hum. Reprod., June 1, 2003; 18(6): 1194 - 1199. [Abstract] [Full Text] [PDF]

				M. Filicori, G.E. Cognigni, P. Pocognoli, C. Tabarelli, D. Spettoli, S. Taraborrelli, and W. Ciampaglia Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration Hum. Reprod., August 1, 2002; 17(8): 2009 - 2015. [Abstract] [Full Text] [PDF]